Howe Jolanda 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Mirum (MIRM) SVP Jolanda Howe Receives Equity Awards
What Happened
Jolanda Howe, SVP & Global Controller of Mirum Pharmaceuticals (MIRM), was granted a total of 21,650 derivative awards on January 28, 2026: 7,680 units, 4,970 units and 9,000 units. Each award was reported at a $0.00 acquisition price (transaction code A — award/grant), meaning these are equity awards (restricted stock units and performance RSUs), not open‑market purchases or sales.
Key Details
- Transaction date: January 28, 2026; Form 4 filed January 30, 2026 (filed within the standard two‑business‑day window).
- Reported grant amounts: 7,680 + 4,970 + 9,000 = 21,650 units. Reported price: $0.00 (award).
- Shares owned after the transaction: Not specified in the filing.
- Footnote highlights from the filing:
- Some awards are time‑based RSUs with a 1‑year cliff (1/4 vests after 1 year) then monthly vesting over 36 months.
- Each restricted stock unit represents the contingent right to one share.
- Some RSUs vest 1/3 on each anniversary over three years.
- A previously granted PSU award (granted Jan 23, 2024) had performance criteria achieved as of Jan 28, 2026; that PSU vests 2/3 on Mar 15, 2026 and 1/3 on Mar 15, 2027.
- Transaction code: A = Award/Grant (derivative awards), not a purchase (P) or sale (S).
Context
These grants are equity compensation subject to service and/or performance vesting schedules and represent future rights to receive common shares if vesting conditions are met. Because this is a grant (not a purchase or sale), it reflects compensation decisions by the company rather than a direct expression of the insider’s buying or selling intent. Some awards (PSUs) have performance conditions that were met and have scheduled vest dates in March 2026 and 2027.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-01-28+7,680→ 7,680 totalExercise: $100.85Exp: 2036-01-27→ Common Stock (7,680 underlying) - Award
Restricted Stock Units
[F2][F3]2026-01-28+4,970→ 4,970 total→ Common Stock (4,970 underlying) - Award
Performance Restricted Stock Units
[F2][F4]2026-01-28+9,000→ 9,000 total→ Common Stock (9,000 underlying)
Footnotes (4)
- [F1]1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
- [F4]On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.